galactosamine has been researched along with propranolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, M; Purcell, WM; Xu, J | 2 |
2 other study(ies) available for galactosamine and propranolol
| Article | Year |
|---|---|
Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers.
Topics: Acetaminophen; Animals; Cell Survival; Diclofenac; Galactosamine; gamma-Glutamyltransferase; Glucose; Hepatocytes; L-Lactate Dehydrogenase; Liver; Male; Models, Biological; Propranolol; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Toxicity Tests; Xenobiotics | 2003 |
Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. II. Spheroid cell spreading inhibition as a new cytotoxic marker.
Topics: Acetaminophen; Animals; Cell Movement; Cell Survival; Culture Media; Diclofenac; Galactosamine; Hepatocytes; Liver; Male; Propranolol; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Toxicity Tests; Xenobiotics | 2003 |